The NeuroStar® TMS Therapy System is a Transcranial Magnetic Stimulation (TMS) system used to treat patients with Major Depressive Disorder (MDD) who have not benefited from antidepressant treatment. This breakthrough depression treatment uses a highly focused, pulsed magnetic field, similar in type and strength to those produced by a magnetic resonance imaging (MRI) machine, to stimulate function in brain regions known to affect mood.
- The NeuroStar TMS Therapy System utilises several unique patented technologies to maximise patient treatments:
- SenStar® Treatment Link – The link to its proven safety record, and effective and tolerable treatment
- MT Assist® – Unique software makes finding the right treatment dose easy
- Precision Pulse TMS™ Technology – Patented Iron Core coil design improves efficiency which increases patient throughput
- Coil Positioning System – Integrated positioning system assures repeatable and accurate treatment.
- TMS TrakStar™ – Proprietary patient database that facilitates TMS reporting and documentation
- Minimal Systemic Side Effects 1, 2, 3
- Demonstrated Durability over 12 months – 68% in response and 45% in remission4
- 1 in 2 patients responded and 1 in 3 achieved complete remission of symptoms5
1. O’Reardon JP, et al. (2007). Efficacy and safety of Transcranial Magnetic Stimulation in the acute treatment of major depression: A multisite randomised controlled trial. Biol Psychiat 62(11):1208-1216.
2. George MS, et al. (2010). Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder: A Sham-Controlled Randomised Trial. Arch Gen Psychiat 67(5):507-516.
3. Janicak PG, et al. (2008). Transcranial Magnetic Stimulation in the treatment of major depression: A comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiat 69(2):222-32.
4. Dunner, D.L., et al. (2014). A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients with Pharmacoresistant Major Depression: Durability of Benefit Over a One-Year Follow-Up Period. J Clin Psych; doi:10.4088/JCP.13m08977.
5. Carpenter LL, et al. (2012). Transcranial Magnetic Stimulation (TMS) for Major Depression: A Multisite, Naturalistic, Observational Study of Acute Treatment Outcomes in Clinical Practice. Depress Anxiety 29(7):587–596.
For more information please visit the NeuroStar website.